InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.099 0.007 (7.61%)+
Announcement
Release
23 Jul 2026 8:27AM
Price at Release
$0.092
Full Release
download
Summary
In its Q4 FY26 report, Alcidion Group Limited achieved a record positive operating cash flow of $7.7 million, leading to an annual operating cash flow of $6.8 million, a 19% increase from FY25. The company reported a cash balance of $20.6 million with no debt as of June 30, 2026. Significant achievements during the quarter included $43.2 million in new sales and renewals, a major $35 million contract with UH Sussex for a seven-year Electronic Patient Record deployment, and the strategic acquisition of Kyra flow products, adding 31 new customers across Australia and New Zealand. Alcidion projects FY26 revenue to reach approximately $51.6 million, marking a 27% increase from the previous year, with EBITDA expected to exceed $5.0 million. As the company moves into FY27, it maintains strong momentum and has scheduled an investor webcast for July 23, 2026.
Key Points
  • Record Q4 FY26 positive operating cashflow of $7.7M.
  • FY26 positive operating cashflow of $6.8M, up 19% on FY25.
  • Cash balance of $20.6M as of 30 June 2026 with no debt.
  • Q4 new sales and renewals totaled $43.2M.
  • Seven-year $35.0M contract with UH Sussex for EPR deployment.
  • Acquisition of Kyra flow products completed, adding 31 new customers.
  • Revenue expected to be ~$51.6M, a 27% increase from the prior year.
  • EBITDA projected to exceed $5.0M.
  • Strong market momentum going into FY27.
  • Investor webcast scheduled for 23 July 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.